Indee Labs (Series A(+))

Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Founders
Ryan Pawell
Company Description
Our hardware is uniquely positioned to efficiently develop and scale the manufacturing of gene-modified cell therapies like chimeric antigen receptor T-cells. Indee Labs powers your research with our patented, non-viral technology to rapidly deliver nucleic acids, proteins, and gene-editing complexes to immune cells while yielding millions to billions of high-quality cells with preserved cell viability and function.
Market
Human Health
Location
United States

Links
Back to Home Back to Biopharma Deals View Funding Announcement